Ro. Jimenez et Bal. Da Fonseca, Recombinant plasmid expressing a truncated dengue-2 virus E protein without co-expression of prM protein induces partial protection in mice, VACCINE, 19(6), 2000, pp. 648-654
A nucleic acid vaccine candidate against dengue-2 virus was constructed to
express a truncated dengue-2 E glycoprotein without concomitant expression
of prM. The truncated E protein was properly expressed even in the absence
of prM. Mice inoculated intramuscularly with the recombinant plasmid contai
ning 94% of the E gene did not respond with anti-dengue antibodies, cellula
r proliferation, or synthesis of cytokines by their lymphoid cells when sti
mulated with purified dengue-2 virus. However, protection was observed in 2
0% of the challenged mice immunized with this recombinant plasmid and the m
ice survived longer than the control group. The low percentage of protectio
n might be explained by a weak activation of the immune system resulting fr
om an imperfect secretion of E due to lack of the prM protein. This study c
orroborates with the hypothesis that prM is important for the processing of
the E glycoprotein and should be incorporated on candidate vaccines engine
ered by recombinant DNA technology. (C) 2000 Elsevier Science Ltd. All righ
ts reserved.